Target Audience

Objectives

Continuing Medical Education

Unapproved and investigational uses of drugs and devices

Faculty Disclosure

Computer Hardware/Software Requirements

This activity is intended for clinicians and researchers interested in practical uses for antifungal therapies. Persons participating should have a working knowledge of basic microbiology and/ or infectious diseases.

After successfully completing this program, participants should be able to:

• Identify the clinical science of echinocandins and the ways in which echinocandin therapy can be utilized in clinical practice
• Recognize the importance of laboratory involvement in disease management
• Understand the latest efforts in echinocandin therapy toward resistant candidiasis
• Compare efficacy of echinocandin therapy with other therapies for candidiasis

Imedex^®, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Imedex, Inc. designates this educational activity for a maximum of 2 category 1 credits toward the AMA Physician's Recognition Award. Each physician should claim only those credits that he/she actually spent in the activity.

Original Release date: June 2004.
Expiration date: June 30, 2005.

The time required to view this program and complete the self-assessment questions is 2 hours. To receive CME credit, view and listen to the educational program. Complete the self-assessment questions, evaluation form, and CME credit request form and submit to:

Imedex, Inc.
70 Technology Drive
Alpharetta, GA, 30005 or
fax to +1 770-751-7334

before June 30, 2005.

CME certificates will be mailed within 3 weeks after receipt of the required documentation. No credit will be awarded for submissions received after June 30, 2005.

This webcast may contain information about investigational or other uses of drugs or devices that are not currently approved by the Food and Drug Administration (FDA) of the United States, or by regulatory authorities in other countries. Participants in the United States should consult the FDA-approved product labeling for complete information about indications, contraindications, precautions, warnings, adverse reactions, dosage and administration for any drug or device mentioned in this program prior to use. Participants from other countries should consult with their respective regulatory authorities.

The opinions expressed are the opinions of the authors and do not necessarily reflect the opinions of Imedex, Inc. or of Merck and Co., Inc. or mycosesstudygroup.org.

As an accredited provider of Continuing Medical Education, Imedex, Inc. is required to ask speakers to disclose any real or apparent conflict of interest they may have as related to the contents of their presentation(s). The existence of commercial or financial interests of speakers related to the subject matter of their presentation(s) should not be construed as implying bias or decreasing the value of their presentation(s). However, disclosure should help participants form their own judgments.

All speakers were independently selected by the organizing committee. Those speakers who disclosed affiliations or financial interests with the commercial organizations involved with products, to which they may refer, are listed here.

Pentium 500 processor or greater

Windows 98/NT/2000/XP or Mac OS 9/X

Microsoft Internet Explorer 5.5 or later

Windows Media Player 6.4 or later

128 MB of RAM

Monitor settings: High color at 800 X 600 pixels

Sound card and speakers

Up